Ketogenic diet late in life may improve cognitive function
A new study led by Drs. Sara Burke and Abbi Hernandez showed that implementing a ketogenic diet even late in life may be beneficial for improving cognitive outcomes.
Posted in
Cognitive Aging News
UF-led consortium aims to accelerate Alzheimer’s research and treatment
MBI and 1Florida ADRC Director Todd Golde, M.D., Ph.D., shines light on UF’s role in a nationwide initiative to combat the disease and his hopes for the future
Number of veterans with Alzheimer’s and other dementias on the rise
Retired Col.​ Dr. Michael Jaffee and Dr. Steven DeKosky explain military-related risks of developing dementia that are detailed in a new paper in the journal Alzheimer’s & Dementia.
Research Snapshots: Drs. Michael Pace & David Borchelt
Study demonstrates that additional proteins misfold in the presence of neurodegenerative disease pathologies.
MBI Director Dr. Todd Golde discusses dementia
Following Sandra Day O'Connor's announcement of her dementia, and possibly Alzheimer's, diagnosis, Dr. Todd Golde explains a dementia diagnosis, current treatments and his hope for the future.
Research Snapshots: Jolie Barter & Dr. Thomas Foster
The role of epigenetics in the process of brain aging and cognitive decline.
Dementia with Lewy bodies study examines end-of-life experiences
Melissa Armstrong, M.D., an assistant professor of neurology, partnered with the Lewy Body Dementia Association to survey the families of patients who had dementia with Lewy bodies.
Challenges in defining inappropriate medication use in Parkinson’s dementia
In a recent editorial in JAMA Neurology, a group of neurologists at at The Fixel Center for Neurological Diseases at UF Health discuss medication trends for Parkinson's disease dementia.
Ted Turner has Lewy body dementia, but what is that?
In The Conversation, Dr. Melissa Armstrong explains LBD, how it's diagnosed and current avenues for researching the disease.
The use of rodent models to study neurodegenerative disease
Dr. Todd Golde and colleagues published a review in Nature Neuroscience highlighting the usefulness and limitations of using mouse models to study neurodegenerative diseases.
